Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-298-2 | CAS number: 7487-88-9
Endpoint summary
Administrative data
Description of key information
No reliable study with magnesium sulphate is present. With potassium sulphate a reliable acute dermal toxicity study in rats (according to OECD 402) has been performed showing an LD50 > 2000 mg/kg bw. Reliable acute oral toxicity studies with rats according to OECD 425, one with potassium magnesium sulphate and another one with ammonium phosphate sulphate have been performed, and both showed LD50s>2000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Value:
- mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
No reliable acute toxicity studies are available for magnesium sulphate. However, several second source publications show a high acute oral toxicity for magnesium sulphate. This is confirmed by reliable acute oral toxicity study performed in rats according to OECD 425 with potassium magnesium sulphate (LD50 > 2000 mg/kg bw). For acute dermal toxicity a reliable OECD, EC and EPA guideline study with potassium sulphate is available, showing an LD50>2000 mg/kg bw. In addition, reliable OECD guideline studies with ammonium sulphate (Yamanaka et all., 1990) also show acute oral and dermal toxicity values (LD50) of > 2000 mg/kg bw. A reliable acute oral toxicity study with ammonium phosphate sulphate also showed an LC50>2000 mg/kg bw. Therefore, acute toxicity studies with two possible routes of exposure are available and thus no acute inhalation study is required. However, a study with ammonium sulphate is available showing an LC50 of > 1200 mg/m3 (highest attainable concentration).
Justification for classification or non-classification
All data available show that magnesium sulphate does not have to be classified for acute toxicity according to Directive 67/548/EC and the CLP Directive.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
